RespiriNTM | Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs
01-05-2019
-30-04-2025
Show more information
Organisation
JANSSEN PHARMACEUTICA NV